심근허혈 : 세계 임상시험 리뷰

※ 본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

심근허혈(Myocardial Ischemia) 치료제 임상시험에 관련된 기본 정보와 데이터를 제공하며, 시험 건수 및 피험자 모집 상황, 단계별 동향, 임상시험을 실시하고 있는 주요 제약 기업 및 연구기관 프로파일 등을 정리하여 전해드립니다.

본 보고서의 개요

조사 범위

지역별 임상시험 상황

• 국가별 임상시험 건수와 평균 피험자수
  • 아시아태평양 주요 5개국의 임상시험 건수
  • 유럽 주요 5개국의 임상시험 건수
  • 북미 주요 국가의 임상시험 건수
  • 중동 및 아프리카 주요 5개국의 임상시험 건수
  • 중남미 주요 5개국의 임상시험 건수

G7 국가에서의 임상시험 건수 : 심혈관질환 치료제 임상시험에서 심근허혈 임상시험 비율

G7 국가의 단계별 임상시험 건수

G7 국가에서의 임상시험 건수 : 진척 상황별

E7 국가에서의 임상시험 건수 : 심혈관질환 치료제 임상시험에서 심근허혈 임상시험 비율

E7 국가의 단계별 임상시험 건수

E7 국가에서의 임상시험 건수 : 진척 상황별

단계별 임상시험 건수

• 진행중인 임상시험 : 단계별

진척 상황별 임상시험 건수

임상시험 목표 달성 상황

일정기간에 채용된 피험자

스폰서 종류별 임상시험 건수

유망한 스폰서

심근허혈 치료제 임상시험에 참여하고 있는 주요 기업

유망한 약제

임상시험 프로파일 개요

부록

List of Tables

• Myocardial Ischemia Therapeutics, Global, Clinical Trials by Region, 2019* 7
• Myocardial Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
• Myocardial Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10
• Myocardial Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 11
• Myocardial Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 12
• Myocardial Ischemia Therapeutics Clinical Trials, North America, Top Countries, 2019* 13
• Myocardial Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 14
• Myocardial Ischemia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 15
• Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials, G7 Countries (%), 2019* 16
• Myocardial Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 17
• Myocardial Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 18
• Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials, E7 Countries (%), 2019* 19
• Myocardial Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 20
• Myocardial Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 21
• Myocardial Ischemia Therapeutics, Global, Clinical Trials by Phase, 2019* 22
• Myocardial Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 23
• Myocardial Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2019* 24
• Myocardial Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2019* 25
• Myocardial Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 26
• Myocardial Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 27
• Myocardial Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 29
• Myocardial Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 30
• Myocardial Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 31

List of Figures

• Myocardial Ischemia Therapeutics, Global, Clinical Trials by Region (%), 2019* 7
• Myocardial Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 8
• Myocardial Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10
• Myocardial Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 11
• Myocardial Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 12
• Myocardial Ischemia Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 13
• Myocardial Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 14
• Myocardial Ischemia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 15
• Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials, G7 Countries (%), 2019* 16
• Myocardial Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 17
• Myocardial Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 18
• Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials, E7 Countries (%), 2019* 19
• Myocardial Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 20
• Myocardial Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 21
• Myocardial Ischemia Therapeutics, Global, Clinical Trials by Phase (%), 2019* 22
• Myocardial Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 23
• Myocardial Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2019* 24
• Myocardial Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2019* 25
• Myocardial Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 26
• Myocardial Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 27
• Myocardial Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 28
• Myocardial Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 30
• Myocardial Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 31
• GlobalData Methodology 241

GlobalData's clinical trial report, "Myocardial Ischemia Global Clinical Trials Review, H2, 2019" provides an overview of Myocardial Ischemia clinical trials scenario. This report provides top line data relating to the clinical trials on Myocardial Ischemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• The report provides a snapshot of the global clinical trials landscape
• Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
• The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
• The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
• The Report provides enrollment trends for the past five years
• Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

• Assists in formulating key business strategies with regards to investment
• Helps in identifying prominent locations for conducting clinical trials which saves time and cost
• Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
• Supports understanding of trials count and enrollment trends by country in global therapeutics market
• Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
• Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

• List of Tables 3
• List of Figures 4
• Report Guidance 5
• GlobalData Clinical Trials Report Coverage 6
• Clinical Trials by Region 7
• Clinical Trials and Average Enrollment by Country 8
• Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
• Top Five Countries Contributing to Clinical Trials in Europe 12
• Top Countries Contributing to Clinical Trials in North America 13
• Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
• Top Five Countries Contributing to Clinical Trials in Central and South America 15
• Clinical Trials by G7 Countries: Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials 16
• Clinical Trials by Phase in G7 Countries 17
• Clinical Trials in G7 Countries by Trial Status 18
• Clinical Trials by E7 Countries: Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials 19
• Clinical Trials by Phase in E7 Countries 20
• Clinical Trials in E7 Countries by Trial Status 21
• Clinical Trials by Phase 22
• In Progress Trials by Phase 23
• Clinical Trials by Trial Status 24
• Clinical Trials by End Point Status 25
• Subjects Recruited Over a Period of Time 26
• Clinical Trials by Sponsor Type 27
• Prominent Sponsors 28
• Top Companies Participating in Myocardial Ischemia Therapeutics Clinical Trials 30
• Prominent Drugs 31
• Clinical Trial Profile Snapshots 32

Appendix 240

• Abbreviations 240
• Definitions 240
• Research Methodology 241
• Secondary Research 241
• About GlobalData 242
• Contact Us 242
• Source 243